Disclosure Of Earnings Per Share [Text Block]

Captor Therapeutics S.A. - Filing #6272138

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Disclosure of earnings per share [text block]
Earnings per share [text block]
Zysk na akcję
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
473.00
30.00
Basic earnings (loss) per share from discontinued operations
0.00
0.00
Basic earnings (loss) per share
473.00
30.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
464.00
31.00
Diluted earnings (loss) per share from discontinued operations
0.00
0.00
Diluted earnings (loss) per share
464.00
31.00
Adjustments to reconcile profit (loss) to numerator used in calculating earnings per share [abstract]
Profit (loss), attributable to owners of parent
64 274 716 PLN
4 165 637 PLN
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.